Cleared Traditional

K152237 - The Entasis Dual-Lead Sacroiliac Implant

K152237 is the FDA 510(k) clearance for The Entasis Dual-Lead Sacroiliac Implant by Corelink, LLC. It is a Class 2 Orthopedic device (product code OUR) cleared through the Traditional 510(k) pathway after a 178-day FDA review.

K152237 · Corelink, LLC · Orthopedic device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Feb 2016
Decision
178d
Days
Class 2
Risk

K152237 is an FDA 510(k) clearance for the The Entasis Dual-Lead Sacroiliac Implant. Classified as Sacroiliac Joint Fixation (product code OUR), Class II - Special Controls.

Submitted by Corelink, LLC (St.Louis, US). The FDA issued a Cleared decision on February 4, 2016 after a review of 178 days - an extended review cycle.

This device falls under the Orthopedic FDA review panel, regulated under 21 CFR 888.3040 - the FDA orthopedic device regulatory framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Orthopedic review framework, consistent with the majority of Class II 510(k) submissions.

View all Corelink, LLC devices

Submission Details

510(k) Number K152237 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received August 10, 2015
Decision Date February 04, 2016
Days to Decision 178 days
Submission Type Traditional
Review Panel Orthopedic (OR)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
56d slower than avg
Panel avg: 122d · This submission: 178d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

Device Classification

Product Code OUR Sacroiliac Joint Fixation
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 888.3040
Definition Sacroiliac Joint Fusion
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Orthopedic devices follow this clearance model.

Regulatory Consultant

Empirical Testing Corp
Kenneth C Maxwell II

The regulatory consultant manages the 510(k) submission process on behalf of the applicant - coordinating technical documentation, predicate strategy and FDA communications. Identifying the consultant behind a submission is a key signal for competitive regulatory intelligence.

Regulatory Peers - OUR Sacroiliac Joint Fixation

All 118
Devices cleared under the same product code (OUR) and FDA review panel - the closest regulatory comparables to K152237.
RIALTO(TM) SI Fusion System, Medtronic Reusable Instruments for Use with the IPC(TM) Powerease(TM) System, and Medtronic Navigated Manual Reusable Instruments for use with the StealthStation(TM) and IPC(TM) Powerease(TM) Systems
K161210 · Medtronic Sofamor Danek · Aug 2016
iFUSE Implant System
K160652 · SI-BONE, Inc. · Jun 2016
iFuse Implant System(R)
K152681 · SI-BONE, Inc. · Mar 2016
iFuse Implant System
K151718 · SI-BONE, Inc. · Oct 2015
iFuse Implant System
K150875 · SI-BONE, Inc. · Jul 2015
SI-BONE iFuse Implant System
K150714 · SI-BONE, Inc. · Apr 2015